FINDER Flu A&B/SARS-CoV-2 Test
Baebies, Inc. · Decision date Mar 30, 2026
What did the FDA decide?
FDA records K252269 as a 510(k) premarket notification, with a decision dated Mar 30, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Microbiology
- Decision date
- Mar 30, 2026
Regulatory record facts
- Identifier
- K252269
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Baebies, Inc.
- Product code
- QOF
- Decision code
- SESE
- Decision date
- Mar 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents.
- Applicant
- Baebies, Inc.
- Product code
- QOF
- FDA device class
- 2
FDA decision timeline
K252269 received
Application receipt date recorded by FDA.
K252269 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QOF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| GenMark Diagnostics, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
Xpert Xpress CoV-2/Flu plusK263333 | Cepheid | 510(k) clearance | Oct 22, 2026 | FDA |
Xpert Xpress CoV-2/Flu plusK263120 | Cepheid | 510(k) clearance | Oct 2, 2026 | FDA |
Xpert Respiratory PanelK261336 | Cepheid | 510(k) clearance | Sep 25, 2026 | FDA |
| Biofire Diagnostics | 510(k) clearance | Sep 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Baebies, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Durham, NC
Sources and methodology
- Original FDA record: K252269
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

